Drug profile · INN
imiglucerase
CEREZYME
imiglucerase (CEREZYME) is a glucocerebroside hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
Drug details — imiglucerase
- US status
- approved
- Class
- Alimentary tract and metabolism (A16)
- Route
- INJECTION
- Patents
- 0
- Programs
- 3
- Data quality
- 0.84
Quick answer
imiglucerase (CEREZYME) is a glucocerebroside hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocerebroside hydrolytic enzyme
Primary target: Glucocerebroside
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is imiglucerase?
imiglucerase (CEREZYME) is a glucocerebroside hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for imiglucerase?
CEREZYME is a marketed brand name for imiglucerase. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of imiglucerase?
imiglucerase has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.